InnoCan Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.63	6.69	5.01	3.89	4.95	11.05
Cash & Short-Term Investments	6.63	6.69	5.01	3.89	4.95	11.05
Cash Growth	4.12%	33.53%	28.91%	-21.47%	-55.22%	229.30%
Accounts Receivable	0.5	0.22	0.25	0.25	0.06	-
Other Receivables	0.8	0.72	0.29	0.42	0.18	0.17
Receivables	1.3	0.94	0.54	0.67	0.24	0.17
Inventory	2.18	2.18	3.32	1.75	1.13	0.51
Prepaid Expenses	0.08	0.07	0.07	0.34	0.45	0.72
Other Current Assets	0.58	0.55	0.22	0.17	0.1	0.08
Total Current Assets	10.77	10.44	9.15	6.8	6.88	12.52
Property, Plant & Equipment	0.08	0.09	0.11	0.14	0.1	0.05
Total Assets	10.85	10.52	9.26	6.94	6.98	12.58
Accounts Payable	0.33	0.24	0.19	0.11	0.1	0.05
Accrued Expenses	0.79	0.73	0.48	0.46	0.32	0.43
Current Portion of Leases	-	-	0.01	0.02	0.01	0
Other Current Liabilities	0.38	0.39	1.57	1.95	0.3	3.08
Total Current Liabilities	1.95	1.36	2.24	2.54	0.73	3.56
Long-Term Debt	0.97	0.93	-	-	-	-
Long-Term Leases	-	-	-	0.01	0.02	-
Total Liabilities	2.92	2.29	2.24	2.55	0.75	3.56
Additional Paid-In Capital	42.21	41.63	40.08	37.18	34.77	33.67
Retained Earnings	-37	-36.03	-34.91	-33.07	-28.37	-24.61
Total Common Equity	5.2	5.6	5.17	4.1	6.39	9.06
Minority Interest	2.72	2.64	1.86	0.28	-0.17	-0.04
Shareholders' Equity	7.93	8.24	7.02	4.39	6.23	9.01
Total Liabilities & Equity	10.85	10.52	9.26	6.94	6.98	12.58
Total Debt	1.42	0.93	0.01	0.03	0.03	0
Net Cash (Debt)	5.21	5.76	5	3.85	4.91	11.05
Net Cash Growth	3.03%	15.19%	29.75%	-21.60%	-55.53%	233.04%
Net Cash Per Share	1.16	1.29	1.16	0.97	1.28	3.20
Filing Date Shares Outstanding	4.5	4.5	4.48	4.32	3.87	3.82
Total Common Shares Outstanding	4.5	4.5	4.46	4.12	3.84	3.82
Working Capital	8.81	9.08	6.91	4.26	6.15	8.96
Book Value Per Share	1.16	1.24	1.16	1.00	1.66	2.37
Tangible Book Value	5.2	5.6	5.17	4.1	6.39	9.06
Tangible Book Value Per Share	1.16	1.24	1.16	1.00	1.66	2.37